| # | Security | Shares | Value | % of Portfolio |
|---|---|---|---|---|
| 1 | Pliant Therapeutics Inc(PLRX) | 3,014,199 | $52.3M | 20.72% |
| 2 | Repare Therapeutics Inc(RPTX) | 2,966,674 | $35.8M | 14.20% |
| 3 | Cullinan Oncology Inc(CGEM) | 3,414,189 | $30.9M | 12.25% |
| 4 | Acelyrin Inc | 2,262,990 | $23.0M | 9.12% |
| 5 | Orchard Therapeutics PLC | 12,315,654 | $14.0M | 5.56% |
| 6 | Larimar Therapeutics Inc(LRMR) | 3,414,468 | $13.5M | 5.35% |
| 7 | Keros Therapeutics Inc(KROS) | 407,633 | $13.0M | 5.15% |
| 8 | Ikena Oncology Inc | 2,180,934 | $9.4M | 3.74% |
| 9 | Ultragenyx Pharmaceutical in(RARE) | 215,000 | $7.7M | 3.04% |
| 10 | Compass Therapeutics Inc(CMPX) | 2,829,712 | $5.6M | 2.21% |
Latest filing, equity positions only
Quarter-over-quarter weight changes
| Sector | Prev % | Curr % | Change |
|---|---|---|---|
| Healthcare | 53.24% | 70.28% | +17.04% |
| Unclassified | 46.76% | 29.72% | -17.04% |
Quarter-over-quarter weight changes by market cap
| Cap Size | Prev % | Curr % | Change |
|---|---|---|---|
| Micro Cap | 28.79% | 38.3% | +9.51% |
| Small Cap | 22.77% | 31.51% | +8.74% |
| Unclassified | 46.76% | 29.72% | -17.04% |
| Mid Cap | 1.69% | 0.47% | -1.22% |
Quarter-over-quarter position changes